An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

Pfizer has abruptly ended its partnership with Acepodia, citing global resource shifts, not Acepodia’s competence. This split ...

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

Choosing dividend stocks is not only about looking at the yield but also ensuring that the company pays regular dividends, ...

Leveraging computerized maintenance management systems software can enhance efficiency, improve quality control, ensure ...

Pfizer remains a strong Buy with robust cost controls, EPS growth, and a promising pipeline, despite challenges. See more on ...

Pfizer ( PFE 1.46%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...